TY - JOUR
T1 - Treatment of non-small cell lung cancer patients with proton beam-based stereotactic body radiotherapy
T2 - Dosimetric comparison with photon plans highlights importance of range uncertainty
AU - Seco, Joao
AU - Panahandeh, Hamid Reza
AU - Westover, Kenneth
AU - Adams, Judith
AU - Willers, Henning
PY - 2012/5/1
Y1 - 2012/5/1
N2 - Purpose: Proton beam radiotherapy has been proposed for use in stereotactic body radiotherapy (SBRT) for early-stage non-small-cell lung cancer. In the present study, we sought to analyze how the range uncertainties for protons might affect its therapeutic utility for SBRT. Methods and Materials: Ten patients with early-stage non-small-cell lung cancer received SBRT with two to three proton beams. The patients underwent repeat planning for photon SBRT, and the dose distributions to the normal and tumor tissues were compared with the proton plans. The dosimetric comparisons were performed within an operational definition of high- and low-dose regions representing volumes receiving >50% and <50% of the prescription dose, respectively. Results: In high-dose regions, the average volume receiving ≥95% of the prescription dose was larger for proton than for photon SBRT (i.e., 46.5 cm 3 vs. 33.5 cm 3; p =.009, respectively). The corresponding conformity indexes were 2.46 and 1.56. For tumors in close proximity to the chest wall, the chest wall volume receiving ≥30 Gy was 7 cm 3 larger for protons than for photons (p =.06). In low-dose regions, the lung volume receiving ≥5 Gy and maximum esophagus dose were smaller for protons than for photons (p =.019 and p <.001, respectively). Conclusions: Protons generate larger high-dose regions than photons because of range uncertainties. This can result in nearby healthy organs (e.g., chest wall) receiving close to the prescription dose, at least when two to three beams are used, such as in our study. Therefore, future research should explore the benefit of using more than three beams to reduce the dose to nearby organs. Additionally, clinical subgroups should be identified that will benefit from proton SBRT.
AB - Purpose: Proton beam radiotherapy has been proposed for use in stereotactic body radiotherapy (SBRT) for early-stage non-small-cell lung cancer. In the present study, we sought to analyze how the range uncertainties for protons might affect its therapeutic utility for SBRT. Methods and Materials: Ten patients with early-stage non-small-cell lung cancer received SBRT with two to three proton beams. The patients underwent repeat planning for photon SBRT, and the dose distributions to the normal and tumor tissues were compared with the proton plans. The dosimetric comparisons were performed within an operational definition of high- and low-dose regions representing volumes receiving >50% and <50% of the prescription dose, respectively. Results: In high-dose regions, the average volume receiving ≥95% of the prescription dose was larger for proton than for photon SBRT (i.e., 46.5 cm 3 vs. 33.5 cm 3; p =.009, respectively). The corresponding conformity indexes were 2.46 and 1.56. For tumors in close proximity to the chest wall, the chest wall volume receiving ≥30 Gy was 7 cm 3 larger for protons than for photons (p =.06). In low-dose regions, the lung volume receiving ≥5 Gy and maximum esophagus dose were smaller for protons than for photons (p =.019 and p <.001, respectively). Conclusions: Protons generate larger high-dose regions than photons because of range uncertainties. This can result in nearby healthy organs (e.g., chest wall) receiving close to the prescription dose, at least when two to three beams are used, such as in our study. Therefore, future research should explore the benefit of using more than three beams to reduce the dose to nearby organs. Additionally, clinical subgroups should be identified that will benefit from proton SBRT.
KW - NSCLC
KW - Photon
KW - Proton
KW - SBRT
UR - http://www.scopus.com/inward/record.url?scp=84859857344&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84859857344&partnerID=8YFLogxK
U2 - 10.1016/j.ijrobp.2011.05.062
DO - 10.1016/j.ijrobp.2011.05.062
M3 - Article
C2 - 21985941
AN - SCOPUS:84859857344
SN - 0360-3016
VL - 83
SP - 354
EP - 361
JO - International Journal of Radiation Oncology Biology Physics
JF - International Journal of Radiation Oncology Biology Physics
IS - 1
ER -